Title : AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.

Pub. Date : 2016 Nov

PMID : 27573426






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Herein, we report AZD5153, a potent, selective, and orally available BET/BRD4 bromodomain inhibitor possessing a bivalent binding mode. AZD5153 bromodomain containing 4 Homo sapiens
2 Unlike previously described monovalent inhibitors, AZD5153 ligates two bromodomains in BRD4 simultaneously. AZD5153 bromodomain containing 4 Homo sapiens
3 The relationship between AZD5153 exposure and efficacy suggests that prolonged BRD4 target coverage is a primary efficacy driver. AZD5153 bromodomain containing 4 Homo sapiens
4 This study establishes AZD5153 as a highly potent, orally available BET/BRD4 inhibitor and provides a rationale for clinical development in hematologic malignancies. AZD5153 bromodomain containing 4 Homo sapiens